Here’s what you should know:
1. Novartis CEO Vas Narasimhan said the company won’t raise the prices of its prescription drugs in 2018, but it will evaluate the healthcare legislative environment as it evolves.
2. Novartis originally planned increases for the third quarter of 2018.
3. The company said in a statement, “We work with governments and healthcare stakeholders in all the countries we serve, to support policies to ensure the development of and access to medicines that can improve and extend our patients’ lives.”
More articles on supply chain:
Key Surgical, ModMed & more — 3 GI company key notes
10 things to know about ASC coding audits
GI residents earn over $64K — Here’s which specialties rake in more
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.